Le Lézard
Classified in: Health
Subject: SVY

Visiongain Report Offers Transformative Insights on $13bn Neurostimulation Devices Market


LONDON, December 10, 2018 /PRNewswire/ --

Global Neurostimulation Devices Market 2019-2029 

Spinal Cord Stimulators, Deep Brain Stimulators, Vagus Nerve Stimulators, Sacral Nerve Stimulators, Cortical Stimulators, Epilepsy, Pain Management, Hearing Loss, Incontinence, Gastroparesis, Parkinson's Disease 

     (Logo: https://mma.prnewswire.com/media/523989/Visiongain_Logo.jpg )

The global neurostimulation devices market will reach $13bn in 2024 and is estimated to grow at a CAGR of 13% from 2024 to 2029. In 2018, the spinal cord stimulators segment accounted for 45% of the global neurostimulation devices market.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 166-page report you will receive 102 charts- all unavailable elsewhere.

The 166-page report provides clear detailed insight into the neurostimulation devices market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope 

? Global Neurostimulation Devices Market from 2019-2029

? Forecast of the Global Neurostimulation Devices market by Product:
? Spinal Cord Stimulators
? Deep Brain Stimulators
? Sacral Nerve Stimulators
? Vagus Nerve Stimulators
? Cortical Stimulators
? Others

Each submarket is further segmented by regional and national market: US, Canada, Germany, France, the UK, Italy, Spain, Rest of Europe, Japan, China, India, Rest of APAC, Latin America, Middle East & Africa

? Forecast of the Global Neurostimulation Devices market by Application:
? Pain Management
? Epilepsy
? Urinary and Fecal Incontinence
? Hearing Loss
? Gastroparesis
? Parkinson's Disease
? Others

Each submarket is further segmented by regional and national market: US, Canada, Germany, France, the UK, Italy, Spain, Rest of Europe, Japan, China, India, Rest of APAC, Latin America, Middle East & Africa

? This report provides individual revenue forecasts to 2028 for these regional and national markets:
? North America: US, Canada
? Europe: Germany, France, United Kingdom, Italy, Spain and rest of Europe
? Asia-Pacific: Japan, China, India and rest of Asia-Pacific
? RoW: Latin America, Middle East & Africa

? Our study discusses the selected leading companies that are the major players in the neurostimulation devices market:
? Advanced Bionics
? Boston Scientific Corporation
? Cochlear ltd
? Cyberonics
? Medtronic
? Neuronetics Inc
? Nervo Corp.
? Cogentic Medical Inc
? St Jude Medical
? NDI Medical

? Our study discusses the factors that drive and restrain the neurostimulation devices market

Visiongain's study is intended for anyone requiring commercial analyses for the neurostimulation devices market. You find data, trends and predictions.

Buy our report today Neurostimulation Devices Market 2019-2029: Spinal Cord Stimulators, Deep Brain Stimulators, Vagus Nerve Stimulators, Sacral Nerve Stimulators, Cortical Stimulators, Epilepsy, Pain Management, Hearing Loss, Incontinence, Gastroparesis, Parkinson's Disease

To request a report overview of this report please contact Sara Peerun at [email protected] or refer to our website: https://www.visiongain.com/report/global-neurostimulation-devices-market-2019-2029/

Did you know that we also offer a report add-on service? Email [email protected] to discuss any customized research needs you may have.

Abbott Laboratories
Advanced Bionics LLC
Alliance BiomedicaPvt Ltd.
Axonics Modulation Technologies
Blackrock
Boston Scientific Corporation
Cameron Health
Cardiac Pacemakers, Inc.
Cochlear AG
Cochlear Holdings NV
Cochlear Ltd.
Cochlear Verwaltungs GmbH
Codman & Shurtleff
Cogentix Medical Inc.
Cyberonics, Inc.
ElectroCore
Enteromedics
EP Technologies
Functional Neuromodulation
Greatbatch
Guidant
IntraPace
LABORIE Medical Technologies
LivaNova
Medtronic
Microtransponder
Morris K. Udall Centers of Excellence for Parkinsons Disease
Neuronetics, Inc.
Neuropace
Neurosigma
Nevro
Nevro Corp.
Otologics
Sonova Holding AG
St. Jude Medical
Stimwave
Symetis SA
Thoratec
Uroplasty Inc.
Zynex

List of Organisations
American Academy of Neurology
Centers for Disease Control and Prevention (CDC)
CFDA
Chinese Food & Drug Administration (CFDA)
Epilepsy Foundation
European Commission
Federal Interagency Forum on Aging-Related Statistics
Food & Drug Administration (US)
Insurance Regulatory and Development Authority (IRDA)
International Labour Organization (ILO)
Ministry of Health, Labor and Welfare (MHLW)
National Health Service (UK)
National Institute of Population and Social Security Research
National Institutes of Health (NIH)
Parkinson's Disease Foundation
World Health Organisation (WHO)

To see a report overview please e-mail Sara Peerun on [email protected]



These press releases may also interest you

at 07:45
Redwood Scientific Technologies Inc. ("Redwood" or "the Company"), a pharmaceutical company, today announced a strategic shift in its product development priorities. The New York-based firm will only focus on enhancing and expanding its nicotine...

at 07:35
Cybin Inc. (Cboe CA:CYBN) ("Cybin" or the "Company"), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative next-generation psychedelic-based treatment options, today announced...

at 07:35
Accuray Incorporated announced today that as part of its commitment to advancing patient care the company has opened a new training center in...

at 07:30
The "Drug Delivery Companies Compendium 2024" directory has been added to ResearchAndMarkets.com's offering. The Drug Delivery Companies Compendium is a cost-effective, time-saving product that answers all of your questions about Drug Delivery...

at 07:30
Arbutus Biopharma Corporation , a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop a functional cure for people with chronic hepatitis B virus (cHBV) infection, today announced that it has scheduled its...

at 07:30
Biomed Israel, the premier international Life Science and HealthTech conference in Israel, will take place on May 21-23, 2024, at the David InterContinental Hotel in Tel Aviv, Israel. The event presents a unique opportunity for global healthcare and...



News published on and distributed by: